To include your compound in the COVID-19 Resource Center, submit it here.

Survey finds Europe top alternative for Chinese life science investors amid CFIUS concerns

A survey of Chinese investors revealed broad concern about U.S. restrictions on foreign investment in the life sciences that is diverting Chinese investments to other countries, with Europe cited as the top alternative for investment.

Sixty percent of respondents said they and their peers are “much less active” in China-to-U.S. life

Read the full 508 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers